Table 1. Clinical Characteristics of the Study Sample by Randomization Group.
| Characteristic | Mean (SD) | |
|---|---|---|
| Treatment group (21 patients [21 eyes]) | Placebo group (11 patients [11 eyes]) | |
| Age, y | 64.3 (10.5) | 65.2 (8.6) |
| Female, No. (%) | 13 (62) | 8 (73) |
| Male, No. (%) | 8 (38) | 3 (27) |
| Baseline | ||
| Mean deviation, dB | −6.8 (3.0) | −7.9 (2.7) |
| PSD, dB | 7.3 (3.1) | 9.5 (3.5) |
| VFI, % | 82.5 (9.8) | 77.7 (10.9) |
| Baseline global RNFL, µm | 64.2 (10.1) | 63.2 (10.7) |
| Study duration, median, IQR, mo | 2.2 (2.0-2.4) | 2.8 (1.0) |
| No. of antiglaucoma medications | 1.8 (1.0) | 2.4 (1.4) |
| Type of medication (prostaglandins), No. (%) | 15 (71.4) | 9 (81.8) |
| Surgery, No. (%) | ||
| Laser | 7 (33.3) | 7 (63.6) |
| Incisional | 9 (42.8) | 3 (27.2) |
Abbreviations: PSD, pattern standard deviation; RNFL, retinal nerve fiber layer; VFI, visual field index.